Biotech VC Funds

Atento Capital is a Tulsa-based venture capital firm founded with the mission of supporting early-stage tech startups, particularly those in underinvested communities. The firm was launched with backing from the George Kaiser Family Foundation, focusing on generating both market returns and social impact by funding innovative companies in the Heartland region of the U.S. Atento primarily invests in seed and early-stage companies, with check sizes ranging from $250,000 to $3 million. They are committed to fostering diversity in entrepreneurship, directing nearly half of their capital to underrepresented founders, including women and founders of color. Notable portfolio companies include RobbieAI, a platform using computer vision to prevent patient injuries, and PatchRx, a health tech solution aimed at improving medication adherence​. Beyond funding, Atento provides hands-on support to startups by offering mentorship, business development guidance, and access to local talent via partnerships with organizations like inTulsa. Their approach is deeply rooted in building long-term success for founders who have traditionally been overlooked by the broader venture capital ecosystem.

Atinum Investment, the venture capital arm of Atinum Partners, is a prominent South Korean investment firm with over $450 million in assets under management. The firm focuses on diverse sectors such as deep tech, artificial intelligence, blockchain, advanced robotics, bio-healthcare, and IT components. They actively invest in early-stage to growth-stage startups with significant global market potential. Notable portfolio companies include CryptoQuant, Allganize, and Klook. Atinum Investment has a global reach, particularly focusing on Southeast Asia, with investments in companies like InstaReM and Fast Five, a South Korean co-working space startup. The team at Atinum Investment includes key figures such as Wan Gee Cho, who specializes in deep tech and SaaS investments, and Peter Na, the Regional Head for Southeast Asia, focusing on investments in the region from the Singapore office. Atinum is committed to providing more than just capital by offering strategic guidance and opening doors to potential customers and partners, ensuring the growth and success of their portfolio companies.

Atlantic Bridge, founded in 2004, is a global growth equity technology firm that focuses on investing in deep technology companies across Europe, the UK, and the US. With over €1 billion in assets under management, the firm has a portfolio of 70 companies and has created over 5,000 jobs. Atlantic Bridge is known for its cross-border value-add strategy, helping portfolio companies expand internationally through its offices in Dublin, London, Munich, Paris, and Palo Alto. The firm's portfolio includes notable companies such as SOC Prime, which specializes in enterprise threat detection and response, and Elisity, which combines Zero Trust Network Access with an AI-enabled Software Defined Perimeter. Other significant investments include Siren, an investigative intelligence platform, and Aizon, which optimizes pharmaceutical manufacturing processes using real-time data and predictive models. Atlantic Bridge has achieved successful exits with companies like Navitas Semiconductor, which recently debuted its GaN Power ICs on Nasdaq, and Mitiga, a provider of hybrid managed services for incident response and readiness. The firm is led by experienced industry professionals, including Managing Partners Elaine Coughlan, Brian Long, and Kevin Dillon, who bring extensive expertise in scaling technology companies and executing successful IPOs and M&As.

FoodLabs, founded in 2015 and based in Berlin, Germany, is a prominent venture capital firm dedicated to investing in innovative startups within the food, health, and sustainability sectors. The firm supports companies aiming to revolutionize how we produce, consume, and think about food, with a mission to create sustainable and healthy solutions for the future. FoodLabs has made a significant impact with its diverse portfolio, which includes companies like ChefCoco, a personalized weekly menu service, and Van Heron Labs, which focuses on biotechnology. The firm has been an early investor in some of the most influential European FoodTech startups, such as Infarm, Meatable, Mushlabs, and Sanity Group. These investments span across various stages, from pre-seed to series B and beyond, demonstrating FoodLabs' commitment to nurturing startups through their growth journey. The team at FoodLabs, led by founder Christophe Maire and managing director Patrick Noller, combines deep industry expertise with a strong network to provide strategic support and resources to their portfolio companies. They are particularly focused on sectors like synthetic biology, climate resilience, and health, aiming to address some of the world's most pressing challenges.

Atlantic Labs, based in Berlin, is a prominent early-stage venture capital firm that supports mission-driven founders across Europe. Founded in 2013, the firm has a focus on investing in transformative technology sectors such as climate tech, digital health, future of work, AI and data, industrial automation, mobility and logistics, fintech, and proptech. Atlantic Labs typically invests at the pre-seed stage, with investment sizes ranging from €25,000 to €5 million or more. They have backed over 215 companies, including notable names like SoundCloud, GetYourGuide, Clue, Vimcar, and Cazoo. The firm emphasizes a hands-on approach, providing not only capital but also strategic guidance and access to a robust network of industry experts to help their portfolio companies grow and succeed. The firm's portfolio reflects its diverse focus areas, supporting companies that aim to redefine various industries through innovative solutions. Examples include digital health companies like Clue, AI and data startups such as Mobius Labs, and mobility ventures like GetYourGuide and Cazoo. Atlantic Labs is led by a team of experienced investors and operators who are committed to supporting entrepreneurs throughout their entire journey. This commitment to fostering innovation and growth has established Atlantic Labs as a key player in the European venture capital landscape.

Atlas Venture is a leading biotech venture capital firm focused on creating and building innovative life science companies. With over 30 years of experience, they have incubated over 70 startups and taken 40 companies public, including Intellia Therapeutics, Kymera Therapeutics, and Generation Bio. Atlas specializes in drug discovery and development, emphasizing areas like gene editing, oncology, and immunotherapy. Headquartered in Cambridge, Massachusetts, Atlas primarily targets U.S.-based startups but maintains a global vision, partnering with top scientific minds. They invest early, often leading seed and Series A rounds, with typical check sizes ranging from $5M to $20M. Atlas's approach is hands-on, actively incubating new ventures and co-founding companies with a strong operational focus. Key figures include Jean-François Formela, who has been instrumental in several high-profile exits and IPOs, and focuses on cutting-edge drug discovery technologies. Founders approaching Atlas should focus on breakthrough science with clear therapeutic applications, as the firm seeks to translate groundbreaking research into life-changing medicines.

Atlas Venture is a leading venture capital firm specializing in early-stage investments in biotechnology and life sciences. Founded in 1980 and based in Cambridge, Massachusetts, Atlas Venture has built a robust portfolio by focusing on groundbreaking biotech innovations. The firm has raised multiple funds, including their most recent Fund XIII at $450 million, which emphasizes their commitment to fueling biotech startups from seed stage through to successful exits​. Notable investments in their portfolio include companies like Intellia Therapeutics, Kymera Therapeutics, and Ikena Oncology. These investments highlight Atlas Venture's dedication to developing therapies that address significant unmet medical needs, particularly in oncology and genetic disorders. Intellia Therapeutics, for instance, is renowned for its gene-editing technologies, while Kymera Therapeutics focuses on protein degradation to treat diseases. Atlas Venture has achieved numerous successful exits, such as the acquisitions of IFM Therapeutics by Bristol-Myers Squibb and Novartis, and the IPO of Generation Bio. These exits underscore the firm’s strategic capability in identifying and nurturing high-potential biotech startups to maturity. The firm is led by a team of experienced partners, including Jean-Francois Formela, Jason Rhodes, and David Grayzel, who bring a wealth of expertise in venture capital and life sciences. This team collaborates closely with entrepreneurs to provide not just capital but also strategic guidance and operational support, leveraging their extensive network within the biotech industry. For startups aiming to partner with Atlas Venture, it is crucial to present innovative solutions with strong scientific foundations and clear pathways to address significant medical challenges. The firm values startups that demonstrate potential for substantial clinical impact and scalability within the healthcare sector.

Atomico, founded in 2006 by Skype co-founder Niklas Zennström, is a leading venture capital firm based in London, with additional offices in Paris, Berlin, and Stockholm. The firm focuses on Series A and beyond investments in disruptive technology companies globally. Atomico's notable investments include Klarna, Truecaller, Lime, Hinge Health, and Rovio, which highlight their strong presence in fintech, healthcare, consumer tech, and gaming sectors. Atomico's investment strategy centers around partnering with mission-driven European founders, providing them with not just capital but also extensive operational support through their Growth Acceleration Team. This team assists with scaling operations, strategic planning, and navigating complex market dynamics. Their typical investment range is from $10 million to $50 million, and they often lead rounds, ensuring significant influence in their portfolio companies' trajectories. The firm is known for its diverse team and deep industry expertise. Key figures include Niklas Zennström, CEO and Partner; Chris Barnes, COO; and Thomas Wehmeier, Partner and Head of Insights, all based in London. This diverse leadership team brings a wealth of experience from various sectors, enhancing their ability to support and scale innovative startups. For startups looking to engage with Atomico, it's crucial to showcase innovative solutions with a potential for significant market impact. The firm is particularly interested in technology-driven companies that can leverage shifts in consumer behavior and technological advancements.

ATP Fund, established in 2014 and headquartered in Austin, Texas, is an early-stage venture capital firm that focuses on deep tech investments aimed at advancing human conditions through scientific innovation. The firm specializes in sectors such as artificial intelligence (AI), biotechnology, cleantech, cybersecurity, enterprise software, healthcare, and robotics. ATP Fund is known for its strategic investments in startups that are tackling some of the most challenging and impactful problems of our time. ATP Fund adopts a contrarian and hands-on approach, often partnering with scientific entrepreneurs at the earliest stages of their ventures, sometimes even at the formation stage via their Proto.n initiative. This strategy reflects their commitment to long-term partnerships and their belief in the transformative potential of cutting-edge technologies. The fund's portfolio includes a variety of high-impact companies like Diligent Robotics, which focuses on healthcare robotics, and Infleqtion, a firm that specializes in quantum technology. These investments highlight ATP Fund's dedication to supporting ventures that have the potential to make significant advancements in their respective fields. ATP Fund collaborates with a wide network of co-investors, including notable names like Texas Venture Labs and Osage University Partners. The firm has also seen successful exits, further establishing its reputation as a key player in the deep tech investment landscape.

ATX Venture Partners, established in 2014 and headquartered in Austin, Texas, is an early-stage venture capital firm. The firm primarily invests in disruptive B2B software, APIs, marketplaces, frontier tech, and applications. Notable investments in their portfolio include companies like Aceable, AlertMedia, and Pensa Systems. Focusing on Seed and Series A stages, ATX Venture Partners operates with a strong preference for businesses that are already generating revenue. They actively invest across the United States, with a particular emphasis on the South-Central region. Their strategy involves partnering with entrepreneurs to create transformative technologies, aiming for category-defining outcomes in their respective industries. ATX Venture Partners is led by a team of experienced professionals including co-founders Chris Shonk, Brad Bentz, and Danielle Allen. Chris Shonk, known for his extensive background in both military operations and business, brings a wealth of experience in tech and consumer service investments. Brad Bentz combines expertise in finance, academia, and IT, while Danielle Allen leverages her extensive Wall Street background, focusing on finance and investments, particularly in space and women-led companies. Their investment approach is marked by a hands-on, collaborative ethos, aiming to propel portfolio companies towards larger growth. Entrepreneurs seeking investment are advised to approach ATX Venture Partners through detailed business plans, highlighting innovative solutions and market traction. Their recent investments, like the $1.7 million funding for Light Frame and the $1.9 million for LUXUS, underscore their commitment to fostering growth in cutting-edge sectors. For startups looking to partner with ATX Venture Partners, demonstrating product-market fit and a clear path to revenue generation is key.

Augment Ventures is a venture capital firm based in Ann Arbor, Michigan, specializing in early-stage investments across North America. The firm, founded in 2011 by Sonali Vijayavargiya, focuses on companies at the intersection of digital innovation and data utilization, particularly in sectors such as supply chain, fintech, industry 4.0, health tech, proptech, climate tech, B2B, and SaaS​. Notable investments by Augment Ventures include companies like LLamasoft, which was sold to Coupa Software for $1.5 billion, Optilogic, a cloud-native supply chain software solution, and Fluree, a platform recognized among the coolest data management companies​. Their portfolio also features innovative companies like Pair Team, Secro, Guardhat, and Crowdz, which span diverse industries from healthcare and fintech to supply chain and industrial safety. Augment Ventures emphasizes partnering with mission-oriented founders and diverse teams to address significant, real-world challenges. They provide not just capital but also strategic guidance and operational support to help startups scale and succeed in a constantly evolving global economy​.

Auriga Partners is a Paris-based venture capital firm established in 1998. The firm specializes in early-stage investments across various sectors, including information technology, life sciences, and cybersecurity. Auriga Partners has a strong focus on supporting high-potential ventures in Europe, North America, and Israel. Notable investments by Auriga Partners include Vade Secure, Nexthink, and Exeliom Biosciences. Vade Secure, a leader in predictive email defense, and Nexthink, a prominent analytics software provider, highlight Auriga’s commitment to backing innovative tech companies. Exeliom Biosciences, a biotech firm focused on the development of microbiome therapeutics, demonstrates their investment in life sciences. Auriga Partners has a robust portfolio with over 171 investments and 77 exits, reflecting their extensive experience and successful track record in venture capital. Their approach involves not only providing capital but also leveraging their expertise and network to support the growth and development of their portfolio companies. The team at Auriga Partners includes seasoned professionals like Philippe Granger, Mathieu Chatain, and Nabil Gharios, who bring significant industry knowledge and investment experience.

AV8 Ventures is a venture capital firm with a focus on early-stage investments in technology and healthcare sectors. Founded by George Ugras, who brings extensive experience from IBM Ventures and Apax Partners, AV8 Ventures operates primarily from Palo Alto and London. The firm leverages its deep expertise in applied AI, cloud computing, and big data to support transformative startups in these fields. The firm's investment strategy centers on identifying high-potential startups and providing them with not only capital but also strategic support and industry connections. AV8 Ventures emphasizes building long-term relationships with its portfolio companies, helping them scale and succeed in competitive markets. Notable investments by AV8 Ventures include companies like GrayMatter, which develops smart robotic solutions for manufacturing, and Precision Neuroscience, focusing on groundbreaking brain technology. These investments highlight AV8's commitment to supporting innovative technologies that address significant challenges in their respective industries. The team at AV8 Ventures, led by Ugras, comprises experienced professionals with backgrounds in venture capital, entrepreneurship, and technology development. This diverse expertise enables AV8 to provide comprehensive support to its portfolio companies, guiding them through various stages of growth and development. For startups looking to partner with AV8 Ventures, it’s essential to demonstrate strong technological foundations, clear market potential, and a vision for scalability and impact in the technology or healthcare sectors​.

Avalancha Ventures is a venture capital firm based in Mexico City, founded in 2015 by Lorenzo Garza and Rodrigo Ocejo. The firm focuses on early-stage investments, typically ranging from $50,000 to $300,000, with the potential for follow-on investments up to $2,000,000. Avalancha Ventures aims to support technology-driven companies that disrupt their target markets and show significant growth potential. Their portfolio includes notable investments such as Bind ERP, a cloud-based ERP platform for Mexican SMBs, and Syncfy, an open finance platform in Latin America. Other significant investments include Appaguitos.com, Bridgefy, WIHOM Software, and Carryt. These investments span across various industries including fintech, telecommunications, software, logistics, and e-commerce​. Avalancha Ventures is committed to helping its portfolio companies navigate their growth journeys, offering not just capital but also strategic support and expertise to help them scale and succeed in competitive markets.

Avalon BioVentures, based in La Jolla, California, is a leading venture capital firm dedicated to early-stage biomedical innovation. With a $135 million fund, ABV1, Avalon BioVentures continues the legacy of Avalon Ventures by focusing exclusively on life sciences. Notable investments include Vertex Pharmaceuticals, Onyx Pharmaceuticals, Amira Pharmaceuticals, and Neurocrine Biosciences. More recent successes include Sitari Pharmaceuticals (acquired by GSK), Calporta (acquired by Merck), and Synthorx (acquired by Sanofi). Avalon BioVentures concentrates on biotechnology and life sciences, investing primarily in companies that are developing groundbreaking therapies for unmet clinical needs. Geographically, the firm focuses on the U.S., leveraging its strong presence in San Diego’s vibrant biotech hub. The firm’s strategy involves more than just capital; it includes active partnership through their integrated life science accelerator, providing essential resources, operational support, and strategic guidance from day one. Avalon BioVentures typically leads investment rounds, with average checks ranging from early seed funding to larger Series A investments. Key team members include Jay Lichter, Ph.D., an experienced biotech executive, Sanford J. Madigan, Ph.D., who has a rich background in corporate financing and business development, and Sergio G. Duron, Ph.D., known for his extensive experience in drug discovery and preclinical development. These leaders, among others, bring a combination of scientific expertise and entrepreneurial acumen, ensuring a hands-on approach to building successful biotech companies. Startups seeking investment should approach Avalon BioVentures with a clear vision for innovation in life sciences and a readiness to engage in a collaborative, entrepreneurial partnership.

Avalon Ventures is a San Diego-based venture capital firm with a focus on early-stage investments, particularly in life sciences and information technology. Founded in 1983, Avalon has a reputation for being one of the pioneering VCs in its field, actively seeking out companies with disruptive technologies and strong potential for market impact. Avalon tends to invest during the seed and Series A stages, with a preference for being the first institutional investor in many of its portfolio companies. The firm has made over 157 investments, with notable portfolio companies like Synthorx, Jnana Therapeutics, and Averon. Avalon is also known for its partnership with GlaxoSmithKline (GSK), which has helped launch several life science ventures through its joint funding efforts. Their long-term approach has led to several successful exits, including IPOs from companies like Kaltura and Janux Therapeutics. Avalon’s investment strategy revolves around identifying and nurturing innovative companies that align with their thesis-driven approach, focusing on emerging trends in both healthcare and tech sectors. The firm operates out of its offices in La Jolla, California, and Cambridge, Massachusetts, allowing it to maintain a strong presence on both coasts of the U.S. and globally.

Avoro Capital Advisors is a global life sciences investment firm based in New York, known for its strategic focus on biotechnology, life sciences, and specialty therapeutics. Founded as venBio Select Advisor, the firm has been instrumental in supporting emerging biotech companies that are driving innovation in the treatment of unmet medical needs. Avoro's investment strategy emphasizes identifying unique or undervalued opportunities in the market, often participating in both public and private investments across the biotech landscape. The firm’s portfolio includes a range of prominent companies such as Immunomedics (acquired by Gilead in 2020), MyoKardia (acquired by Bristol Myers Squibb), and Mirati Therapeutics, among others. Avoro is recognized for its hands-on approach, offering not just financial backing but also deep intellectual support to foster scientific breakthroughs. Avoro Ventures, a venture capital arm of the firm, extends this mission by focusing on early-stage investments in the drug discovery and healthcare tools sectors. The team is led by Managing Partner and Portfolio Manager Behzad Aghazadeh, who is highly regarded in the industry for his expertise in biopharmaceutical investments. With a comprehensive approach that includes rigorous risk management and a strong focus on innovation, Avoro Capital continues to be a key player in advancing biopharmaceutical developments.

Awesome People Ventures is an early-stage venture capital firm that focuses on investing in Web3 and other transformative technologies that are poised to reshape how we live and work. Founded by Julia Lipton, a seasoned entrepreneur and investor, the fund is dedicated to supporting founders who are not only innovative but also committed to building companies with integrity, inclusivity, and long-term impact. The firm primarily invests in startups at the pre-seed and seed stages, with a particular emphasis on those operating in the Web3 space—a sector that encompasses blockchain, decentralized finance (DeFi), and other emerging technologies that enable new forms of digital ownership, governance, and value exchange. Awesome People Ventures is driven by the belief that Web3 represents a pivotal technological and cultural shift, with the potential to fundamentally alter various industries and create more equitable systems. In addition to providing capital, Awesome People Ventures offers hands-on growth support, including strategic guidance, mentorship, and access to an exclusive talent network. This holistic approach ensures that the startups in their portfolio have the resources they need to navigate the challenges of early-stage growth and scale successfully. The firm is backed by a group of high-profile investors, including Marc Andreessen and Chris Dixon, who are known for their expertise in the crypto and technology sectors. Awesome People Ventures is committed to backing a diverse range of founders and ideas, aiming to foster innovation that leads to a more inclusive and equitable future.

Axelys is a dynamic technology transfer and innovation organization based in Quebec, dedicated to advancing the commercialization of public research. Launched in 2021, it was formed to centralize and streamline efforts from three prior institutions—Aligo Innovation, Sovar, and Univalor—creating a unified approach to foster innovation across the province. Funded by the Quebec Ministry of Economic Development, Axelys partners closely with universities, hospitals, and research centers, helping to transform academic discoveries into market-ready solutions. Axelys focuses on sectors like biotechnology, healthcare, green technologies, and other high-impact areas, working to develop intellectual property assets and create startups from promising research. Through comprehensive support that includes consulting, business development, and intellectual property management, Axelys helps researchers navigate the commercialization journey, turning innovative ideas into sustainable businesses. The organization’s mission emphasizes building stronger connections between academia and industry, with the goal of making Quebec a leader in innovation and economic growth. Leading the charge is CEO Paule De Blois, who brings over 20 years of experience in managing innovation projects. Her leadership focuses on fostering a collaborative ecosystem that bridges scientific research with entrepreneurial ambitions. Axelys is backed by a diverse team and a start-up committee led by Chief Innovator Luc Sirois, which includes key figures from academia and industry. Together, they aim to increase Quebec's competitiveness, boost the creation of high-quality jobs, and contribute to economic and social prosperity by harnessing the full potential of public research.

Axial VC is a San Francisco-based venture capital firm, founded in 2019 by Joshua Elkington. The fund is focused on early-stage investments in the biotechnology sector, with a particular emphasis on innovative therapeutics and healthcare technologies. Axial has a strong track record of backing cutting-edge startups, with notable investments including CHARM Therapeutics, which leverages AI in biotechnology, and Replay, a leader in gene therapy. Geographically, Axial’s portfolio spans across key biotech hubs in the U.S. and Europe, such as San Francisco, San Diego, and London. The fund is known for participating in sizeable funding rounds, with an average check size of around $19M, although it does not typically lead these rounds. Instead, Axial often co-invests alongside prominent firms like Khosla Ventures, General Catalyst, and OrbiMed, ensuring a collaborative approach to scaling its portfolio companies. Axial’s strategy is heavily centered on identifying transformative technologies at the intersection of biology and data science. The fund actively seeks out startups with strong scientific foundations and the potential to disrupt traditional healthcare paradigms. For entrepreneurs looking to connect with Axial, the firm values a clear demonstration of technical innovation and market potential. The team, based primarily in San Francisco, is hands-on, providing not just capital but also strategic guidance to help startups navigate the complexities of early-stage growth.

Axon Partners Group, founded in 2006 and headquartered in Madrid, Spain, is a global investment and consulting firm specializing in technology and innovation. The firm operates across multiple investment strategies, including direct venture capital investments, funds of funds, and growth equity. Axon has a strong presence in Europe, Israel, and the U.S., and it focuses on sectors such as digital, life sciences, deep tech, and sustainable technology. Axon Partners Group has made numerous notable investments. For instance, they invested in ISR, a Spanish technology company specializing in artificial vision systems for quality control in industry. ISR's Specular Vision® technology addresses complex inspection needs for transparent and reflective surfaces in various sectors like automotive and metallurgy. Axon's investment aims to support ISR's international expansion and strengthen its position as a leader in machine vision technology. Other significant investments include Finizens, a wealth management firm offering digital robo-advisory services, and Holaluz, an independent energy company in Spain providing green power and gas to businesses and households. Additionally, Axon has supported companies like Nextmol, which focuses on accelerating the design of new chemicals through molecular modeling and AI, and Glamping Hub, a global platform for unique outdoor accommodations. Axon's investment approach combines financial support with strategic consulting to help portfolio companies scale and innovate. They are committed to sustainability and investing in technologies that drive the transition to a sustainable world.

B Capital Group, founded in 2015 by Eduardo Saverin, Raj Ganguly, and Howard Morgan, is a global multi-stage investment firm. The firm focuses on investing in technology, healthcare, and climate sectors, supporting companies from seed to late-stage growth. With $7+ billion in assets under management, B Capital operates out of eight global locations, including New York, San Francisco, Los Angeles, Singapore, Beijing, and Hong Kong. B Capital's portfolio includes over 160 companies. Notable investments are in firms like Icertis, an AI-powered contract lifecycle management platform; Synack, a crowdsourced cybersecurity testing platform; and Khatabook, a digital bookkeeping solution for small businesses. These investments reflect B Capital's focus on transformative technologies that have the potential to reshape industries. The firm leverages its strategic partnership with Boston Consulting Group (BCG) to provide portfolio companies with expert advice, operational support, and strategic connections, helping them scale efficiently and effectively across global markets. B Capital's recent initiatives include the closure of their third growth fund series at $2.1 billion, emphasizing their commitment to supporting high-growth startups in the enterprise, fintech, and healthcare tech sectors. B Capital's investment approach is characterized by value-add investing, where they offer comprehensive support throughout the business development lifecycle. This includes advisory services on entering new markets, talent acquisition, and strategic business development, ensuring their portfolio companies achieve sustainable growth and success.

b2venture is a European venture capital firm, originally known as btov Partners, focusing on early-stage investments in both digital and industrial technologies. Founded in 2000, the firm invests in high-growth companies across sectors like AI, fintech, biotech, deep tech, and insurtech. With a network of angel investors, b2venture offers not just capital but also strategic support and mentorship to help scale innovative startups. The firm typically invests between €250,000 and €3.5 million, primarily at the Seed and Series A stages, but also supports follow-on rounds. Their portfolio spans a diverse range of industries, including companies like DeepL, Raisin, and Marvel Fusion. b2venture is particularly keen on businesses that demonstrate strong technological potential and scalability across European and global markets. Headquartered in Saint Gallen, Switzerland, with additional offices in Berlin and Luxembourg, b2venture manages over €100 million annually. They leverage their strong community of co-investors and partners to drive innovation, aiming for long-term growth in their portfolio companies.

B37 Ventures is a venture capital firm based in San Francisco, California, founded in 2013. The firm operates on a unique platform that facilitates the exchange of innovation and scale between startups and multinational corporations. This platform allows B37 Ventures to validate product-market fit and curate scalability through the global reach of its diverse corporate investors. The firm focuses on investing in transformative companies across various industries, including industrial and manufacturing, business services, consumer products, and life sciences and healthcare​ (VC Fund List)​. B37 Ventures typically engages with businesses at early stages, providing operational support, strategic guidance, and access to a vast network of corporate partners. B37 Ventures has a notable portfolio that includes companies like Dexterity, an AI-based automation tool and robotics company for managing warehouses, which became a unicorn in 2021. Other recent investments include Ansa, Windfall Bio, and Metaplane, emphasizing their active participation in funding innovative technologies. The team at B37 Ventures includes Managing Partners Rodrigo Sanchez Servitje and David Hite, among others, who bring extensive experience and a hands-on approach to supporting their portfolio companies. For startups looking to partner with B37 Ventures, highlighting strong innovation potential and the ability to scale within their focused industries can be advantageous. The firm's strategic connections and industry expertise provide significant value to their portfolio companies.

Babel Ventures is a Silicon Valley-based venture capital firm that focuses on early-stage investments, particularly in biotech and deep tech. The firm aims to support high-impact founders who are tackling some of humanity's most pressing challenges. Since its inception, Babel Ventures has positioned itself as a leader in consumer biotech, backing startups that have the potential to drive significant changes in consumer behavior and systemic improvements. The firm's team, led by Ryan Bethencourt and Ba Minuzzi, among others, is known for its multidisciplinary approach, blending expertise in science, technology, and entrepreneurship. This allows them to partner effectively with revolutionary startups that are pioneering innovative solutions across various sectors. Babel Ventures launched its first fund, Babel Fund I, and continues to develop new funds and special purpose vehicles (SPVs) to support visionary entrepreneurs. Their portfolio includes companies that are making strides in fields like healthcare, sustainability, and consumer products, all underpinned by cutting-edge biotech and deep tech innovations​.

Backed VC is a human-centric venture capital firm based in London, known for its early-stage investments across Europe. Since its inception, Backed VC has supported over 80 companies, including notable names like FabricNano, Sky Mavis, Hoxton Farms, and Ruka Hair. The firm typically invests at the Seed stage, with average ticket sizes ranging from €500K to €2.5M. Backed VC’s investment strategy focuses on fostering strong relationships with founders, viewing them as the most crucial asset of any company. They emphasize a collaborative approach, providing extensive support through their proprietary Seed to Series A Founder Development Platform, which offers masterclasses, tools, and services to help founders navigate the complexities of scaling their businesses. This platform assists with everything from hiring to preparing for subsequent funding rounds, emphasizing leadership development and mental health support. The firm operates with a community-centric ethos, creating a robust intra-portfolio network where founders can share experiences and resources. This includes workshops, the BACKED Buddy Programme, and informal gatherings that facilitate deeper connections among portfolio companies.

Backend Capital is an investment powerhouse focused on nurturing the next wave of innovative startups. Notable investments include Secureframe, Trove, and other high-potential tech ventures. This fund zeroes in on companies that are at the intersection of software engineering and data-driven business models, emphasizing industries like cybersecurity and AI. Geographically, Backend Capital predominantly targets startups in North America, with a keen eye on burgeoning tech hubs. The fund’s strategy revolves around backing visionary founders early, typically leading seed rounds with an average check size that varies based on the company’s potential and needs. Backend Capital's investment philosophy is built on deep engagement, often taking an active role in guiding startups through their growth journey. They prefer to be approached through warm introductions, valuing strong referrals within the tech community. The fund's funnel is curated through a mix of proactive outreach and strategic networking at key industry events. The team is spearheaded by industry veterans like Matt and Eric, who bring a wealth of experience from their respective backgrounds in high-stakes venture capital and hands-on startup development. Their unique approach combines rigorous technical evaluation with a genuine passion for empowering entrepreneurs. Backend Capital stands out by not just investing capital but also committing to the long-term success of its portfolio companies, making it a formidable player in the venture capital landscape.

BackingMinds is a Swedish venture capital firm founded in 2016 with a mission to support startup entrepreneurs who are typically overlooked by traditional VC networks. The firm focuses on identifying and investing in high-potential founders from underrepresented backgrounds, particularly those outside major tech hubs or those not fitting the conventional startup mold. Currently, BackingMinds is investing from its second fund, which has raised around €50 million. The firm has a diversified portfolio, including companies like CemVision in building products, TrusTrace in supply chain traceability, and Transfer Galaxy, a digital remittance platform. These investments reflect BackingMinds' commitment to uncovering and nurturing talent in areas that are often missed by other investors. The team, led by founding partners Sara Wimmercranz and Susanne Najafi, is based in Stockholm and operates with a hands-on approach. They are particularly known for backing women and immigrant-led startups or businesses located outside Sweden's traditional tech ecosystem, including cities beyond Stockholm.

Bain Capital Ventures (BCV) is a prominent venture capital firm that focuses on investing in early to growth-stage companies across several key sectors including fintech, infrastructure software, application software/SaaS, and commerce. With over $10 billion in assets under management, BCV operates from offices in the Bay Area, New York City, and Boston. Notable investments in BCV’s portfolio include successful companies like DocuSign, LinkedIn, Redis Labs, Rapid7, and Bill.com. These investments highlight BCV’s ability to identify and support transformative companies across diverse industries. The firm typically invests in stages ranging from seed to growth equity, providing capital from $1 million to $100 million per investment​. BCV's investment strategy is deeply rooted in building strong partnerships with founders, offering targeted support from founding to IPO and beyond. Their team of seasoned professionals, including partners like Matt Harris, Merritt Hummer, and Scott Friend, bring a wealth of experience and industry expertise to help portfolio companies scale and succeed. For startups looking to engage with BCV, it is beneficial to demonstrate innovation and potential in key areas such as fintech, digital infrastructure, and commerce technology. BCV’s extensive network and hands-on approach can provide significant strategic advantages to growing companies.

Bain Capital Double Impact is the impact investing arm of Bain Capital, focusing on companies that generate strong financial returns while also delivering measurable social and environmental impact. The firm primarily invests in three core areas: Health and Wellness, Education and Workforce Development, and Sustainability. They target companies that are poised to make a significant impact in these fields, such as improving access to affordable healthcare, advancing educational opportunities, and promoting sustainable business practices. Their approach involves proactive sourcing of opportunities, deep due diligence on both the financial and impact potential of investments, and active partnership with portfolio companies to drive growth and impact. Bain Capital Double Impact is committed to long-term value creation, leveraging the broader Bain Capital platform to provide resources and expertise to their portfolio companies. Notable investments include companies like Cotopaxi, known for its sustainable outdoor gear, and Meteor Education, which supports transformative learning environments. The firm also emphasizes rigorous impact measurement and management, ensuring that their investments achieve sustained impact even at the exit stage.

Balderton Capital is a prominent venture capital firm based in London, specializing in early-stage investments across Europe. Established in 2000 as Benchmark Capital Europe, it became independent in 2007 and has since managed over $2.1 billion in funds. The firm focuses on backing technology and internet startups, and has invested in over 230 companies. Notable investments include Betfair, MySQL, Revolut, Depop, and THG (The Hut Group). These companies have achieved significant exits, with Betfair going public in 2010 and MySQL being acquired by Sun Microsystems in 2008. Balderton's current portfolio features innovative companies like GoCardless, ComplyAdvantage, and Darktrace. Balderton Capital operates both early-stage and growth funds, investing between $1 million and $20 million in Series A rounds and up to $50 million in growth stages. The firm has a sector-agnostic approach but typically invests in fintech, health tech, SaaS, and enterprise software. The leadership team includes partners like Bernard Liautaud and Rana Yared, who bring extensive experience and strategic insights. Balderton also offers robust support to its portfolio companies through its "Build with Balderton" platform, which provides resources in talent, marketing, finance, and legal services. Startups looking to partner with Balderton should highlight their potential for significant impact and scalability. The firm values detailed pitches and prefers to be approached through its network​.

Baltic Sandbox Ventures is a Vilnius-based venture capital firm focused on early-stage investments in deep tech and life sciences startups. Founded in 2018, the firm aims to nurture and develop the Baltic region’s ecosystem by backing R&D-driven startups that tackle complex technical challenges with potential for large-scale commercial applications. Their investments span across sectors like AI, biotechnology, cybersecurity, and precision medicine, supporting both software and hardware innovations. With a portfolio of over 23 investments, including companies like Black Swan Space and Biohifas, Baltic Sandbox Ventures typically co-invests with angel investors and other venture funds. The firm offers a range of support through incubation and acceleration programs, providing up to €400,000 in funding to promising startups. Their unique approach involves working closely with scientific founders, ensuring that they have the right team and intellectual property protections in place. Led by general partners Sandra Golbreich, Andrius Milinavičius, and Erik Bhullar, Baltic Sandbox Ventures has positioned itself as one of the most active early-stage investors in the Baltic region, helping to bridge the gap between research and commercial viability​.

BAM Ventures, based in Los Angeles, is an early-stage venture capital firm co-founded by Brian Lee, known for his successful ventures such as LegalZoom, ShoeDazzle, and The Honest Company. The firm focuses on consumer-centric startups, leveraging their deep operational experience and extensive network to support ambitious founders. BAM Ventures has a diverse portfolio that includes notable companies like The Honest Company, Honey, Tala, Wondery, and Scopely. They have successfully exited several investments, including Outdoor Voices, ClassPass, and fuboTV. BAM Ventures is committed to investing in innovative companies that disrupt the status quo and resonate deeply with consumers. The firm primarily invests in early-stage companies, providing not only capital but also hands-on support, mentorship, and access to their network. They are particularly passionate about the Los Angeles startup ecosystem, seeing it as a natural hub for consumer-focused businesses.

Bantam Group is a venture capital firm and advisory service based near Boston, Massachusetts. Founded by Joe Caruso, the firm emphasizes deep, personal relationships with entrepreneurs and provides a range of support including investment, strategic advice, and hands-on management. Bantam Group's investment focus spans various industries such as software, web services, materials/semiconductors, energy, security, analytical instrumentation, business services, life sciences, and retail/consumer sectors. They are particularly drawn to novel and big ideas, as well as simple concepts executed with passion. Notable investments include HubSpot, Constant Contact, Acquia, and Crashlytics. The firm's geographic focus is primarily on the greater Boston area, preferring to work closely with founders they can meet in person or where there are existing relationships with board members or other investors. Bantam Group has a flexible approach, considering unproven technologies and investing in both stable and troubled situations, with transaction sizes ranging from $10,000 to several million dollars. For entrepreneurs looking to engage with Bantam Group, it is essential to demonstrate high integrity and candid communication. They seek relationships defined by mutual respect and rapport, often going beyond typical investor roles to serve as mentors, coaches, and advocates for their portfolio companies.

Baruch Future Ventures (BFV) is a San Francisco-based venture capital firm dedicated to investing in early-stage companies that focus on climate technology and resource management. Founded by Tom Baruch, a veteran investor with over three decades of experience, BFV leverages its deep industry expertise to support innovations that address critical global challenges, particularly in resource-scarce and climate-sensitive markets. BFV’s investment strategy centers around companies that are pioneering solutions in climate restoration, resource scarcity, and sustainability. The firm’s portfolio includes companies that are transforming power infrastructures, supply chains, and materials manufacturing. Notable investments include partnerships with Breakthrough Energy Ventures, founded by Bill Gates, in companies like Aeroseal and Fervo Energy. Tom Baruch, the founder of BFV, has a storied career in venture capital, including founding CMEA Capital and Formation 8, which were instrumental in launching multiple successful companies, including 10 that achieved unicorn status. BFV prides itself on its ability to identify and scale innovative technologies that can lead to significant environmental and economic impacts. With a strong track record of generating returns and fostering groundbreaking companies, BFV remains a key player in advancing the climate economy through strategic investments in innovative and sustainable technologies.

BASF Venture Capital GmbH (BVC) is the corporate venture arm of BASF, focused on investing in early to mid-stage companies that align with the group's strategic priorities. Established in 2001, BVC targets innovative sectors including decarbonization, circular economy, agricultural technology (AgTech), new materials, digitization, and disruptive business models. Its global presence spans key hubs like Mannheim, Toronto, Boston, Los Angeles, Shanghai, and Sao Paulo, enabling it to connect startups with BASF's extensive network of research, partners, and clients worldwide. BVC manages an evergreen fund of approximately €250 million, which allows for flexibility in investment timelines. Typically, it engages in seed to Series B rounds, emphasizing strategic alignment with BASF’s core business areas. The venture team collaborates closely with portfolio companies, providing not only financial backing but also access to BASF's industry expertise and resources, helping startups scale and penetrate new markets. The firm's portfolio includes diverse ventures such as IntelliSense.io (AI for industrial efficiency), Computomics (predictive breeding in agriculture), and Essentium (industrial 3D printing). Additionally, BVC has invested in various technology funds, including partnerships with accelerators like Alchemist to stay connected with emerging trends and innovations. Led by a team of seasoned professionals across multiple continents, BVC's approach focuses on fostering innovation that contributes to sustainability and future-ready solutions for the chemical and broader industrial sectors.

Basis Set Ventures, founded in 2017 and headquartered in Menlo Park, California, is a venture capital firm that focuses on early-stage investments in artificial intelligence and automation. The firm aims to invest in companies that transform how people work, focusing on scalable infrastructure, intelligent collaboration, automated workflows, and autonomous machines. Their diverse portfolio includes companies like Assembled, a workforce management platform; Ergeon, which leads in outdoor home construction through its tech platform; and Path Robotics, known for autonomous welding robots. Other notable investments are Quince, a company democratizing luxury goods, and Trendsi, which automates supply chain management for modern commerce businesses. Basis Set Ventures emphasizes supporting companies from seed stages, typically writing checks between $1 million and $3 million. They provide more than just financial backing, leveraging their extensive network and deep expertise to help their portfolio companies scale effectively.

Bayern Kapital, founded in 1995 and based in Landshut, Germany, is a key venture capital firm focused on supporting high-tech startups and scale-ups in Bavaria. With nearly 30 years of experience, the firm manages around €700 million and has invested in over 320 Bavarian high-tech companies. Bayern Kapital offers investments ranging from €250,000 to €25 million per company, targeting sectors such as biotechnology, medical technology, software and IT, environmental technology, and new materials. The firm's investment approach emphasizes long-term partnerships, acting as a co-investor alongside private investors to support startups through various growth phases from seed to scale-up. Bayern Kapital prides itself on fostering innovation and entrepreneurship in Bavaria, aiming to drive job creation and economic development in the region. Some notable investments in their portfolio include companies like ProGlove, Immunic Therapeutics, and Sphera. Bayern Kapital's strategy is to offer not just financial support but also leverage their extensive network to help startups connect with potential investors, partners, and customers, thereby enhancing their growth prospects. Key team members include Wolfgang Härtl, Investment Director, who leads their dedicated team of over 40 professionals with diverse academic and professional backgrounds, contributing to their robust support system for portfolio companies​.

BBG Ventures is a New York-based venture capital fund that focuses on early-stage investments in women-led technology companies. The firm, which evolved from AOL's #BUILTBYGIRLS initiative, aims to support and inspire women and girls in the tech economy. BBG Ventures was founded in 2014 and is committed to backing diverse founders who are creating consumer applications and services that make lives simpler, better, and more enjoyable​. BBG Ventures targets sectors such as consumer technology, FinTech, and healthcare, with typical investments ranging from $500,000 to $1 million. They lead or co-lead Seed and Pre-Seed rounds, supporting founders who have a deep, intuitive understanding of the problems they aim to solve​. Notable investments include companies like Zola, Modsy, Spring Health, Blueland, Lola, Starface, and Pymetrics. The fund is led by a team dedicated to fostering innovation and supporting underrepresented entrepreneurs. They provide more than just capital, offering strategic guidance and leveraging their extensive network to help founders succeed​.

BDC Capital, a subsidiary of the Business Development Bank of Canada (BDC), offers a wide range of specialized financing options, including venture capital, growth and transition capital, and growth equity. BDC Capital aims to support innovative Canadian businesses at various stages of growth, from early-stage startups to well-established companies looking to expand. Notable investments by BDC Capital include companies such as Clearpath Robotics, which specializes in autonomous mobile robots, and Bench, a financial services firm providing bookkeeping services to small businesses. Another significant investment is Ritual, a mobile order-and-pay platform for local restaurants. These investments highlight BDC Capital's focus on high-potential technology-driven companies across various industries. BDC Capital's approach involves not just providing financial support but also offering strategic guidance and leveraging their extensive network to help companies scale effectively. They have a strong commitment to fostering innovation and sustainability within the Canadian entrepreneurial ecosystem. The firm operates out of multiple offices across Canada, ensuring a robust national presence to support businesses in all regions. Their investment strategy emphasizes sectors like clean technology, healthcare, information and communication technology, and industrial and agricultural technologies.

BDMI (Bertelsmann Digital Media Investments) is the venture capital arm of Bertelsmann, based in New York City. The firm focuses on early-stage investments, managing both a seed fund and a traditional early-stage fund. BDMI typically invests between $500,000 to $5 million in sectors such as B2B, fintech, consumer, and media. For their seed fund, BDMI looks for products or services that are already live in the marketplace with early signs of product-market fit. They generally do not lead seed stage investments but prefer to join syndicates with a lead investor already in place. This strategy allows them to leverage the expertise of lead investors while providing crucial early-stage funding. BDMI’s notable investments include companies like Fatherly, Suzy, Inverse, DramaFever, Food52, and BarkBox. These investments reflect the firm’s commitment to backing innovative companies that are disrupting their respective industries. BDMI’s connection to Bertelsmann provides their portfolio companies with access to a vast network of resources and industry expertise, helping them scale and succeed in competitive markets. The firm prides itself on supporting its portfolio companies beyond just financial investment. By leveraging Bertelsmann's extensive network and resources, BDMI offers strategic guidance and operational support, helping startups navigate challenges and achieve their growth objectives. This holistic approach to venture capital makes BDMI a valuable partner for startups looking to make a significant impact in the digital media landscape.

BeAble Capital, established in 2016 and headquartered in Madrid, Spain, focuses on early-stage investments in deep science and industrial technologies. Their primary mission is to advance technologies from academic and research institutions into market-ready products, aligning with the United Nations Sustainable Development Goals. BeAble Capital's investment sectors include New Space, New Energy, New Materials, Agro & Food, Environment, Healthcare & Wellbeing, Medtech, Robotics, and AI. Notable investments in their portfolio include companies like Alen Space, which develops small satellites, and A4Cell, which specializes in single-cell monitoring tools. Another significant investment is in Alcyon Photonics, a firm that designs and manufactures photonic integrated circuits. BeAble Capital is led by founders Almudena Trigo, David López, and other partners. They emphasize a hands-on approach in the early development stages, including proof of concept, scale-up, and pre-industrial phases, providing critical support to transform scientific discoveries into commercially viable products. Their strategy involves close collaboration with universities, research centers, and industrial companies to identify promising projects, focusing on technologies that address unmet needs in high-growth markets. The firm has made over 50 investments, reflecting its commitment to fostering innovation and industrial growth in Spain and beyond.

Beast Ventures is a venture capital firm based in London, focusing on early-stage investments in deep tech and transformative technologies. Established in 2015, Beast Ventures targets startups across the UK and Continental Europe that are working on breakthrough engineering, applied science, and technology (hence the acronym BEAST). The firm emphasizes investments in frontier technologies that hold the potential for significant impact in areas such as health, climate, and society. Beast Ventures typically invests at the seed stage, providing support to founders from the inception of their companies through various stages of growth. The firm’s investment portfolio spans diverse industries including artificial intelligence, biotech, cybersecurity, climate tech, and more. Notable investments include companies like Ochre Bio, which focuses on developing RNA therapies for liver disease, and Nutropy, a biotech startup creating sustainable food products. The fund's investment strategy is geared towards achieving outsized returns by backing startups that push the boundaries of science and technology, particularly those with the potential to create significant societal impact. Beast Ventures offers flexible investment sizes, ranging from $100,000 to $2 million, and is known for its deep commitment to supporting cutting-edge innovation​.

Bee Partners, founded in 2009, is a pre-seed venture capital firm based in San Francisco. The firm focuses on investing in deep tech startups that are at the forefront of human-machine convergence. Their primary areas of investment are Human-Machine Interaction, Machine-to-Machine Learning, and Biological Machines. Notable portfolio companies include Rapid Robotics, which develops AI-powered robots for industrial automation, and InnerPlant, a company that provides plant-based bio-signals for agricultural efficiency. Other significant investments are in companies like Embroker, a commercial insurance platform, and New Culture, which produces animal-free dairy products​​. Bee Partners has been instrumental in supporting innovative startups through early investments and strategic guidance. They have a strong track record of helping their portfolio companies secure follow-on funding from leading venture capital firms​.

Benchmark Capital is a premier venture capital firm known for its early-stage investments in transformative companies. Notable investments include eBay, Twitter, Uber, Instagram, and Snapchat, showcasing their knack for identifying high-potential startups. They focus on sectors such as social media, mobile technology, cloud computing, and enterprise software, typically investing at the seed and Series A stages. Benchmark primarily operates within the United States, with offices in San Francisco and Menlo Park. Their investment strategy emphasizes hands-on support and close collaboration with entrepreneurs, aiming to drive startups to achieve market leadership. The firm is known for its unique equal partnership model, ensuring that all partners have an equal say in decision-making processes. With an average check size varying from $1 million to $20 million, Benchmark often leads investment rounds, bringing significant value through strategic guidance and robust industry networks. Founders looking to engage with Benchmark should be prepared with a strong vision and the ability to demonstrate potential for large-scale impact. The firm is led by a team of seasoned investors, including partners like Peter Fenton, Bill Gurley, and Sarah Tavel, who bring extensive experience and a track record of successful exits. This powerhouse team leverages their expertise to provide unparalleled support to their portfolio companies, driving innovation and growth across various industries​.

Benhamou Global Ventures (BGV) is a Silicon Valley-based venture capital firm founded by Eric Benhamou in 2004. Specializing in early-stage investments, BGV focuses on Enterprise 5.0, which combines artificial intelligence with human ingenuity to drive significant productivity improvements. Their portfolio includes notable companies like Totango, Virtana, and Grid Dynamics. BGV has a strong emphasis on cross-border innovation, sourcing startups from global innovation hubs such as France, Israel, and India. This strategy leverages the firm's deep operational expertise and global network to help startups scale in the U.S. and beyond. Approximately 60% of BGV's portfolio companies are founded outside Silicon Valley. The firm recently closed its fourth fund at $110 million, continuing its focus on ethical AI solutions that address data privacy and security concerns while avoiding biases related to race, gender, or age. BGV is committed to providing both financial and human capital, ensuring their portfolio companies receive the necessary support to grow and succeed globally. Eric Benhamou, the founder, brings over 40 years of experience in the IT industry and has participated in numerous IPOs and M&As. His extensive background includes leadership roles at 3Com and Palm, along with significant venture capital experience

Beringea is a transatlantic venture capital firm with a significant presence in the UK and the US, managing over $900 million in assets. Founded in 1988, Beringea has made a name for itself by investing in high-growth companies across sectors such as healthcare, clean technology, media, consumer services, SaaS, and technology. Notable investments from Beringea include successful exits like D3O, ContactEngine, and Inskin Media, showcasing their ability to nurture and grow impactful businesses. Their portfolio also features promising companies like MPB, Flywheel, Asterra, Moonshot, and Akadeum, which highlight their focus on innovation and scalability. Beringea’s investment strategy involves early and growth-stage funding, with typical investments ranging from $2 million to $10 million. They emphasize scalable business models targeting large markets and have a strong track record of leading funding rounds and providing significant operational support to their portfolio companies. Geographically, Beringea operates out of Farmington Hills, Michigan, and London, with additional offices and operations supporting their global reach. The firm's team includes experienced partners like Michael Gross and Stuart Veale, who bring extensive industry knowledge and leadership to the table.

Berkeley SkyDeck is UC Berkeley's premier startup accelerator, integrating the extensive resources of one of the world's top universities with a robust venture fund. Launched as a partnership between the Haas School of Business, the College of Engineering, and the Office of the Vice Chancellor for Research, SkyDeck combines traditional accelerator consulting with academic expertise and research resources​. The Berkeley SkyDeck Fund, with $85 million under management, invests in startups participating in the accelerator program and those with Berkeley affiliations. Each startup in the accelerator receives an initial investment of $200,000. The fund is known for its high activity, making over 100 investments in just three years, backed by prominent VCs like Sequoia Capital and Mayfield Fund. SkyDeck provides startups with access to a vast network of advisors, industry partners, and UC Berkeley alumni, helping them with sales, hiring, and further financing introductions. This network-driven approach has proven successful for alumni startups like DeepScribe and SuperAnnotate, which have raised significant funds and achieved substantial growth. The accelerator supports a diverse range of startups from various sectors and stages, including biotech, hardware, consumer products, and enterprise solutions. SkyDeck also emphasizes diversity, equity, and inclusion, actively working to support underrepresented founders.

Bessemer Venture Partners (BVP), headquartered in San Francisco, is one of the oldest venture capital firms in the United States. Established in 1911, BVP has a long history of investing in early- and growth-stage companies across various industries, including technology, healthcare, and consumer sectors. Some of their notable investments include Shopify, LinkedIn, DocuSign, Pinterest, and Yelp​. BVP is known for its systematic approach to venture capital, leveraging deep industry insights and a decentralized decision-making process. This allows individual partners significant autonomy to invest across different stages, industries, and geographies. The firm has offices not only in the U.S. but also in India, Israel, and the UK​. BVP has raised multiple funds over the years, including a $3.85 billion early-stage fund in 2021 and a $780 million buyout fund under BVP Forge in 2022. These funds reflect their strategy of supporting startups from inception through to growth and eventual exit​ . Their "Anti-Portfolio" is a unique feature on their website, showcasing major investment opportunities they missed, including companies like Apple and eBay, highlighting their commitment to transparency and learning from past decisions​ ​. With a focus on fostering innovation and supporting dynamic founders, Bessemer Venture Partners continues to be a significant player in the global venture capital landscape.

Betaworks is a product-focused, seed-stage venture capital firm based in New York City and San Francisco. Founded by John Borthwick, the firm invests in pre-seed and seed-stage startups, typically with check sizes ranging from $250,000 to $750,000. Betaworks is known for its thematic approach, immersing itself in emerging technologies and user behaviors to identify and nurture high-potential startups. Betaworks has built and invested in notable companies such as Giphy, Dots, bitly, Tweetdeck, and Chartbeat. Their investments also include Twitter, Tumblr, Kickstarter, Medium, Hugging Face, and RecRoom. The firm operates Betaworks Camp, a cohort-based investment and product development program that delves into specific tech themes such as AI, gaming, and decentralization. The team at Betaworks includes John Borthwick, Jordan Crook, and Jonathan Chin, among others, who bring extensive experience in technology, media, and venture capital. Betaworks continues to foster innovation through its community-focused initiatives and strategic investments in the latest technological trends.